EMcision (Acquired) is Profiled in this Database

Updated At 24 Mar, 2018

Partial description of this company

Endoscopic device for tumor ablation via ERCP using radiofrequency energy in patients with advanced and inoperable pancreatic cancer and cholangiocarcinoma

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of EMcision (Acquired) plus 4768 other startups.

Start Free 7 Day Trial Now

Learn More About EMcision (Acquired)

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

CEO presentation